Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Medmira Inc (MIR.VN)

Medmira Inc (MIR.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 48,821
  • Shares Outstanding, K 697,446
  • Annual Sales, $ 241 K
  • Annual Income, $ -4,524 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 0.81
  • Price/Sales 210.83
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.01
  • Most Recent Earnings $0.00 on 12/30/25
  • Next Earnings Date N/A
  • Annual Dividend & Yield (Fwd) N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING TSX Biotechnology

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.060 +16.67%
on 02/10/26
0.070 unch
on 02/27/26
+0.005 (+7.69%)
since 01/27/26
3-Month
0.060 +16.67%
on 02/10/26
0.080 -12.50%
on 12/17/25
unch (unch)
since 11/26/25
52-Week
0.060 +16.67%
on 02/10/26
0.125 -44.00%
on 03/03/25
-0.045 (-39.13%)
since 02/27/25

Most Recent Stories

More News
Upcoming Meeting Dates - January 26, 2026

Toronto, Ontario--(Newsfile Corp. - January 26, 2026) - The following is a list of Upcoming Meeting Dates announced this week for Reporting Issuers in Canada. The data is supplied by Issuing Companies...

EQB.TO : 115.32 (-0.90%)
PRME.CN : 0.0600 (-7.69%)
SKRR.VN : 0.250 (-5.66%)
CYF.VN : 0.030 (unch)
NOP.CN : 0.1350 (-10.00%)
AIML.CN : 0.0400 (-11.11%)
CRI.VN : 0.135 (+3.85%)
BLN.TO : 6.75 (+0.30%)
ATI.VN : 0.020 (unch)
PPX.VN : 0.305 (-1.61%)
DFSC.VN : 2.600 (+1.96%)
LOT.VN : 0.070 (unch)
MedMira Inc. and Lovell Announce Partnership to Increase Access to Reveal(R) G4 HIV-1/2 rapid test for VA, Department of Defense

HALIFAX, NS / ACCESS Newswire / April 17, 2025 / MedMira Inc. (MedMira) (TSXV:MIR) and Lovell® Government Services announced today that they have partnered to serve federal healthcare systems such as...

MIR.VN : 0.070 (unch)
MedMira Reports Second Quarter Results FY2025

HALIFAX, NS / ACCESS Newswire / April 1, 2025 / MedMira Inc. (MedMira) (TSXV:MIR), reported today on its financial results for the quarter ended January 31, 2025.

MIR.VN : 0.070 (unch)
MedMira Announces Partnership with MediGroup Physician Services in the United States

HALIFAX, NS / ACCESS Newswire / February 27, 2025 / MedMira Inc. (MedMira) (TSXV:MIR) announced today its partnership with MediGroup, a leader in the US health care industry since 1999. This new partnership...

MIR.VN : 0.070 (unch)
MedMira Announces Exclusive Distribution Agreement with Trimedic Inc. for Canada

HALIFAX, NS / ACCESS Newswire / February 25, 2025 / MedMira Inc. (MedMira) (TSXV:MIR) announced today its exclusive distribution agreement with Trimedic Inc. for the Canadian market. This partnership allows...

MIR.VN : 0.070 (unch)
MedMira Receives Investigational Testing Authorizations for Multiplo(R) TP/HIV Self-Test and Non-Professional Use Applications

HALIFAX, NS / ACCESS Newswire / January 21, 2025 / MedMira Inc. (MedMira) (TSXV:MIR) announced today that it has received Investigational Testing Authorizations (ITAs) from Health Canada to begin clinical...

MIR.VN : 0.070 (unch)
MedMira Receives Health Canada Approval for Its Reveal(R) G4 Rapid HIV-1/2 Test for Point-of-Care Use

HALIFAX, NS / ACCESSWIRE / January 14, 2025 / MedMira Inc. (MedMira) (TSXV:MIR) announced today that it has received today the approval from Health Canada for its Reveal®Rapid G4 HIV-1/2 Test (Reveal®...

MIR.VN : 0.070 (unch)
MedMira Receives Investigational Testing Authorization for its Multiplo(R) Complete Syphilis (TP/nTP) Antibody Test

HALIFAX, NS / ACCESSWIRE / January 9, 2025 / Today, MedMira Inc. (MedMira) (TSXV:MIR) announced that its received investigational testing authorization (ITA) from Health Canada to begin clinical trials...

MIR.VN : 0.070 (unch)
MedMira Reports First Quarter Results FY2025

HALIFAX, NS / ACCESSWIRE / December 30, 2024 / MedMira Inc. (MedMira) (TSXV:MIR), reported today on its financial results for the quarter ended October 31, 2024.

MIR.VN : 0.070 (unch)
MedMira receives Health Canada approval for its Multiplo(R) Rapid (TP/HIV) Test for Syphilis and HIV

HALIFAX, NS / ACCESSWIRE / December 24, 2024 / MedMira Inc. (MedMira) (TSXV:MIR) announced today that it has received today, on December 24, 2024, the approval from Health Canada for its Multiplo® Rapid...

MIR.VN : 0.070 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

MedMira Inc is a biotechnology company engaged in the research, development, and manufacturing of rapid diagnostics and technologies. The company operates in one reportable operating segment, rapid diagnostic products and services. Its product line includes HIV, COVID-19, syphilis, Multiplex, Miriad...

See More

Key Turning Points

3rd Resistance Point 0.070
2nd Resistance Point 0.070
1st Resistance Point 0.070
Last Price 0.070
1st Support Level 0.070
2nd Support Level 0.070
3rd Support Level 0.070

See More

52-Week High 0.125
Fibonacci 61.8% 0.100
Fibonacci 50% 0.093
Fibonacci 38.2% 0.085
Last Price 0.070
52-Week Low 0.060

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar